Aloprim

Product manufactured by Mylan Institutional Llc

Application Nr Approved Date Route Status External Links
NDA020298 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Aloprim (allopurinol Sodium) For Injection Is Indicated For The Management Of Patients With Leukemia, Lymphoma, And Solid Tumor Malignancies Who Are Receiving Cancer Therapy Which Causes Elevations Of Serum And Urinary Uric Acid Levels And Who Cannot Tolerate Oral Therapy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Allopurinol ALLOPURINOL ZINC13298313

Comments